Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical or Medical Treatment for Pediatric Type 2 Diabetes
NCT04128995Phase 4Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Dec 2019
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, open-label trial in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Glycemic Control at 1 year. Started Dec 2019; status: active, not recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04128995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04128995.